Nektar Therapeutics Financial Forecast
In-Depth Earnings Estimates
|
Current Quarter
Feb 08
|
Next Quarter
Mar 09
|
Current Year
Feb 08
|
Next Year
Feb 09
|
|
|---|---|---|---|---|
| Average Estimate | ($0.30) | ($0.26) | ($1.42) | ($1.15) |
| Number of Analysts | 6 | 1 | 7 | 6 |
| High Estimate | ($0.26) | ($0.26) | ($1.21) | ($0.47) |
| Low Estimate | ($0.35) | ($0.26) | ($1.55) | ($1.46) |
| Year Ago EPS | ($0.13) | ($0.44) | ($0.91) | ($1.42) |
| Growth Rate | (128)% | 40.91% | (56.36)% | 19.06% |
| Consensus Recommendation: | Hold |
|---|
Market Data provided by Interactive Data Managed Solutions.
Earnings Data provided by Zacks.
